UUID: 4F3E197A- 9731- 427C- AZAB- 2l1586A1C717eBd

 

 

IIIIIIIIIIITIIIIIIIiIIiiiﬁiiiiiIiﬁI IIIIII lllllllllll

0" I III I IIIIIed ma APPROVED

IIIIIIIIII IIIIIIIIIIII IIIIIII IIIIII MULTI-MEDIA SYSTEMS, INC.
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII _ Formed _
“1-0-2 Clinical Case Report

(For Collection of Cancerous Tissue)

Crilev II '

    

67W (”CW/“Mpg,
M No! (9504/3
gm; WW cs0?
/L.r 57.96/11

  

W; Hl- :10 F“

9|!- ”SW“ I'.r run our p,
:m .
Q: is circle): V e

    

._-...- . V.- -... .wv

 

 

[Informed Consenti

 

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

A

 

 

Name of Physician or Study Coordinator Signatiire .7 £7 Date

 

IClinical Information!

0

I nf Birth (

 

Cl Single Married 7
Genderl. ‘ weIgnt Cl Divorced El Widow Blood Pressure Heart Rate
El Male ﬁemale ,( 25E mm" 1"} T37 7 "1
0
item . HISTORY 012% PRESENT ILLNESS‘ : .

chiefComplaints: T w 16...: L11, Raw/{3
symptom“ IDA/w WA, ~W mm ((51: MI W MW

[\L. ._LD
*VI VIqW ov‘

Clinical Flndlngs.«-\ Wm inmv (“iii 7% (”IF 1W (Lax 2,.ng IWM (1M

Performance Scale (Karnofsky Score): 3 MI

DIOO Asymptomatic 0 80-90 Symptomatic but Fully Ambulatory I: 60-70 Symptomatic, in bed less than 50% of day
:I 40-50 Symptomatic, in bed more than 50% of day, but not bed ridden D 20-30 Bed Ridden

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

. CURREN'I‘LMEDICATIONS ' = $753!. 5*. ‘ ‘ '

 

 

 

 

 

 

 
 
  

 

 

 

 

DruL V 1 Dose Route Frequency Date (mm/dd/WY‘I) /
/ / To /

W O l / To / /

, , / / To / /

/ / To / /

/ / To / /

 

 

 

 

   

 

 

‘ PAST MEDICAL HISTORY

Date Treatment

 

 

   

 

 

 

 

 

 

 

 

 

=§ OB/GYN HISTORY: " at
Menopausal Status Date of First Menses # of Pregn_ancles
El Pre-menopausal - W‘. 0-2,? L
til/PerikMenopausal Date of Last Menses # 01' Live Birth!
I Post-menopausal WW 4
I Blrth Control: [3 Condom [J Oral Contract,..ve ‘7 Cl IUD El Hormone Replacement
i D Other: Therapy:

 

 

 

I
I , .. . L: HISTOR:

I Smokl l-l

Alcohol Consum
Duratlon

. Use
I Duration

 

    
  
   
 
  
 

Test
HIV
B
H C

AF P
Other:

  
   

       
    
          
  

     
    
     
 

 

Cl Positive:
[:1 Positive:
Cl Positive:
D Positive:

E1 Positive:
D Positive:
Cl Positive:
C1 Positive:

     
     

       

CIN
I:

D
Cl

 

     

       

    
    

  
 
  

  

D Negative CI Positive: CI Negative D Positive:

B/T Cell Markers:

 

sr' "

 

 

 

DIAGNOSTIC STUDIES::'->-..a‘,; ' "
Results

Ultrasound
X-Ra

.. CLINICAE DIAGNOSIS

Location of

Clinical Date of Diagnosis
N M Stage:

 

Ereatment Information]
CADTREA

Tumor
Detailed Location

Extension of Tumor

L Nodes
Location of L
Palpable, Non-Dissected Lymph Nodes , ‘

Dissected Lymph Nodes

Distant Metastasis
Detailed

ical
'r N M

":NEOADJUVEN'PETHERAPY? "
Dose Route

Pathology Form

 

' Specimen Information]

Collected by: .. . ‘ Date: fime:

 

Date: ‘ ime:

 

Preserved by: , ,.

Para Block
Diseased Nomal Diseased Normal Normal Diseased Normal
‘20 .
Time to LN2 Time to Formalin to LN2
mm

Tumor
Size Distance to NAT

X

Nodes
# Examined # Metastaslzed

Distant Metastasis

Notes:

 

Cell
Demonic

 

 

 

Pearl Gland
“tied:
5"“ r17 7 ,
2. CellularDi enntlallon: I J7,
Well Moderately Poor
(Y

 

 

 

 

 

 

Nuclear

.HistologicalDiagnosis: BALM/77V] WWI. C441)? W [(314 é‘L
I Comments. M ’M ‘L : Wrzymmﬁmw A!

l/l/I-

.i q ’ Due
Director. Research W-

m RESEAROI use cum.
mosarcommm. unmoatsrswr
unwrap/um nmkrorrmo

 

